A multicenter clinical phase II study of FOLFOXIRI plus bevacizumab as first-line therapy in patients with metastatic colorectal cancer: QUATTRO study
Oki, Eiji, Kato, Takeshi, Bando, Hideaki, Yoshino, Takayuki, Muro, Kei, Taniguchi, Hiroya, Kagawa, Yoshinori, Yamazaki, Kentaro, Yamaguchi, Tatsuro, Tsuji, Akihito, Iwamoto, Shigeyoshi, Nakayama, GoroLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2018.01.011
Date:
February, 2018
File:
PDF, 875 KB
english, 2018